2020: An Innovation Odyssey? FDA’s Ganley Pushes For Forward-Thinking
This article was originally published in The Tan Sheet
Executive Summary
Growth in the OTC drug industry has stalled because the industry failed to think towards the future a decade ago, according to FDA OTC Drug Products Division Director Charles Ganley, MD